PMID- 37023958
OWN - NLM
STAT- MEDLINE
DCOM- 20230731
LR  - 20230731
IS  - 1535-7732 (Electronic)
IS  - 1051-0443 (Linking)
VI  - 34
IP  - 8
DP  - 2023 Aug
TI  - Comparison between Suprapapillary and Transpapillary Uncovered Self-Expandable 
      Metallic Stent Placement for Perihilar Cholangiocarcinoma.
PG  - 1400-1408
LID - S1051-0443(23)00265-8 [pii]
LID - 10.1016/j.jvir.2023.03.031 [doi]
AB  - PURPOSE: To compare the effectiveness, adverse events (AEs), stent patency, and 
      patient survival with suprapapillary and transpapillary uncovered self-expandable 
      metallic stent placement for perihilar cholangiocarcinoma. MATERIALS AND METHODS: 
      A single-center retrospective study of 54 patients with inoperable perihilar 
      cholangiocarcinoma who underwent percutaneous transhepatic biliary stent 
      placement between January 1, 2019, and August 31, 2021, was conducted. According 
      to stent location, the patients were classified into 2 groups: suprapapillary (S) 
      and transpapillary (T). Demographic data, Bismuth-Corlette classification, type 
      and location of the stent, laboratory data, postprocedural AEs, procedural 
      success, stent occlusion, reintervention rate, and mortality were compared 
      between the groups. RESULTS: Stent placement was suprapapillary in 13 (24.1%) 
      patients and transpapillary in 41 (75.9%) patients. Mean age was higher in Group 
      T (78 vs 70.5 years; P = .046). Stent occlusion rates were similar in the 2 
      groups (Group S, 23.8%; Group T, 19.5%), as were AE rates, the most common being 
      cholangitis (Group S, 23.1%; Group T, 24.4%). There were no significant 
      differences in revision rate (Group S, 7.7%; Group T, 12.2%) and 30-day mortality 
      rate (Group S, 15.4%; Group T, 19.5%). Ninety-day mortality rate was 
      statistically significantly higher in Group T (46.3% vs 15.4%; P = .046). 
      Preprocedural bilirubin level was higher in Group T, as were postprocedural 
      leukocyte and C-reactive protein (CRP) levels. CONCLUSIONS: Suprapapillary and 
      transpapillary stent placement procedures were similar in terms of procedural 
      success, occlusion rate, revision rate, postprocedural AEs, and 30-day mortality. 
      Ninety-day mortality rate and postprocedural leukocyte and CRP levels were higher 
      in Group T, although these patients were also older and had higher preprocedural 
      bilirubin levels.
CI  - Copyright (c) 2023 SIR. Published by Elsevier Inc. All rights reserved.
FAU - Borges, Ana P
AU  - Borges AP
AD  - Department of Radiology, Centro Hospitalar e Universitario de Coimbra, Coimbra, 
      Portugal; Faculty of Medicine, University of Coimbra, Coimbra, Portugal. 
      Electronic address: anapsborges0593@gmail.com.
FAU - Silva, Antonio V
AU  - Silva AV
AD  - Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
FAU - Donato, Paulo
AU  - Donato P
AD  - Department of Radiology, Centro Hospitalar e Universitario de Coimbra, Coimbra, 
      Portugal; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
LA  - eng
PT  - Journal Article
DEP - 20230405
PL  - United States
TA  - J Vasc Interv Radiol
JT  - Journal of vascular and interventional radiology : JVIR
JID - 9203369
RN  - RFM9X3LJ49 (Bilirubin)
SB  - IM
MH  - Humans
MH  - Aged
MH  - *Klatskin Tumor/diagnostic imaging/therapy
MH  - Retrospective Studies
MH  - *Bile Duct Neoplasms/diagnostic imaging/therapy
MH  - Stents
MH  - Bilirubin
MH  - *Cholestasis
MH  - *Cholangiocarcinoma
EDAT- 2023/04/07 06:00
MHDA- 2023/07/31 06:42
CRDT- 2023/04/06 19:26
PHST- 2022/09/24 00:00 [received]
PHST- 2023/03/05 00:00 [revised]
PHST- 2023/03/26 00:00 [accepted]
PHST- 2023/07/31 06:42 [medline]
PHST- 2023/04/07 06:00 [pubmed]
PHST- 2023/04/06 19:26 [entrez]
AID - S1051-0443(23)00265-8 [pii]
AID - 10.1016/j.jvir.2023.03.031 [doi]
PST - ppublish
SO  - J Vasc Interv Radiol. 2023 Aug;34(8):1400-1408. doi: 10.1016/j.jvir.2023.03.031. 
      Epub 2023 Apr 5.